Titanium dioxide nanoparticle-modified screen-printed electrode for erlotinib determination
Original scientific paper
DOI:
https://doi.org/10.5599/admet.3437Keywords:
Electrochemical sensing, differential pulse voltammetry, therapeutic drug monitoringAbstract
Background and purpose: Erlotinib (ERL), a first-generation epidermal growth factor receptor tyrosine kinase inhibitor drug that is used in non-small cell lung cancer treatment, requires precise therapeutic drug monitoring owing to its narrow therapeutic window and significant inter-patient pharmacokinetic variability; existing chromatographic methods, while robust, are resource-intensive and incompatible with point-of-care settings, necessitating the development of simpler, cost-effective electroanalytical alternatives. Experimental approach: A titanium dioxide nanoparticle-modified screen-printed electrode (TiO₂NP@SPE) was fabricated via a facile single-step modification and comprehensively characterized by scanning electron microscopy - energy dispersive X-ray Analysis, Fourier transform infrared spectroscopy, X-ray diffraction and electrochemical impedance spectroscopy; electrochemical performance was evaluated by cyclic voltammetry and differential pulse voltammetry, and analytical validation was performed in human serum using the standard addition method. Key results: The TiO₂NP@SPE demonstrated markedly enhanced electron transfer kinetics over the bare SPE, yielding a well-defined linear response with a competitive limit of detection, high sensitivity, and intra- and inter-day serum recoveries within acceptable precision limits, alongside excellent selectivity against physiologically relevant interferents and structurally related anticancer agents. Conclusion: This work developed a disposable screen-printed electrode sufficient to achieve sensitive, selective, and accurate quantification of ERL in human serum using TiO₂NP@SPE as a promising, clinically translatable platform for point-of-care therapeutic drug monitoring in oncology; future efforts should address the elevated detection limit relative to the bare electrode and extend validation to real patient plasma samples to fully confirm clinical applicability.
Downloads
References
[1] Y. Zhang, S. Gao, X. Zhu, Z. Fang, J. Sun, L. Zhao. Polymorphisms of drug-metabolizing enzymes and transporters contribute to the individual variations of erlotinib steady state trough concentration, treatment outcomes, and adverse reactions in epidermal growth factor receptor-mutated non-small cell lung cancer patients. Frontiers in Pharmacology 11 (2020) 664. https://doi.org/10.3389/fphar.2020.00664 DOI: https://doi.org/10.3389/fphar.2020.00664
[2] R.B. Verheijen, H. Yu, J.H.M. Schellens, J.H. Beijnen, N. Steeghs, A.D.R. Huitema. Practical recommendations for therapeutic drug monitoring of kinase inhibitors in oncology. Clinical Pharmacology and Therapeutics 102 (2017) 765-776. https://doi.org/10.1002/cpt.787 DOI: https://doi.org/10.1002/cpt.787
[3] M.H. Cohen, J.R. Johnson, Y.F. Chen, R. Sridhara, R. Pazdur. FDA drug approval summary: erlotinib (Tarceva) tablets. The Oncologist 10 (2005) 461-466. https://doi.org/10.1634/theoncologist.10-7-461 DOI: https://doi.org/10.1634/theoncologist.10-7-461
[4] V.W. Zhu, A.B. Schrock, S.M. Ali, S.I. Ou. Differential response to a combination of full-dose osimertinib and crizotinib in a patient with EGFR-mutant non-small cell lung cancer and emergent MET amplification. Lung Cancer: Targets and Therapy 10 (2019) 21-26. https://doi.org/10.2147/LCTT.S190403 DOI: https://doi.org/10.2147/LCTT.S190403
[5] J. Carter, P. Tadi. Erlotinib, in StatPearls [Internet], Treasure Island (FL): StatPearls Publishing. 2026. https://www.ncbi.nlm.nih.gov/books/NBK554484/
[6] M. Kim, K. Ryu, H. Kim, H. Lee, J. Lim, H. Kim, M.J. Chang. Population pharmacokinetics of erlotinib in patients with non-small cell lung cancer (NSCLC): a model-based meta-analysis. Computers in Biology and Medicine 186 (2025) 109682. https://doi.org/10.1016/j.compbiomed.2025.109682 DOI: https://doi.org/10.1016/j.compbiomed.2025.109682
[7] W. Brugger, N. Triller, M. Blasinska-Morawiec, W. Curran, D.R. Camidge, T. Csőszi. Prospective molecular marker analyses of EGFR and KRAS from a randomized, placebo-controlled study of erlotinib maintenance therapy in advanced non-small-cell lung cancer. Journal of Clinical Oncology 29 (2011) 4113-4120. https://doi.org/10.1200/JCO.2010.31.8162 DOI: https://doi.org/10.1200/JCO.2010.31.8162
[8] G.H. Long, G. Zalcman, J. Cadranel, A. Depierre, B. Milleron, O. Molinier. Side effects of long-term administration of erlotinib in patients with non-small cell lung cancer. Journal of Thoracic Oncology 5 (2000) 1477-1480. https://doi.org/10.1097/jto.0b013e3181e981d9 DOI: https://doi.org/10.1097/JTO.0b013e3181e981d9
[9] J.S. Kang, M.H. Lee. Overview of therapeutic drug monitoring. Korean Journal of Internal Medicine 24 (2009) 2687654. https://doi.org/10.3904/kjim.2009.24.1.1 DOI: https://doi.org/10.3904/kjim.2009.24.1.1
[10] N. Widmer, C. Bardin, E. Chatelut, A. Paci, J. Beijnen, D. Levêque. Review of therapeutic drug monitoring of anticancer drugs part two - targeted therapies. European Journal of Cancer 50 (2014) 2020-2036. https://doi.org/10.1016/j.ejca.2014.04.015 DOI: https://doi.org/10.1016/j.ejca.2014.04.015
[11] M. Schmidinger, G.G. Steger. Erlotinib: another candidate for the therapeutic drug monitoring of targeted therapy of cancer? A pharmacokinetic and pharmacodynamic systematic review of literature. Therapeutic Drug Monitoring 36 (2014) 567-576. https://doi.org/10.1097/ftd.0000000000000097 DOI: https://doi.org/10.1097/FTD.0000000000000097
[12] M.C. García-Alvarez-Coque, J.J. Baeza-Baeza, G. Ramis-Ramos. Relevance of therapeutic drug monitoring of tyrosine kinase inhibitors in routine clinical practice: a pilot study. Pharmaceutics 14 (2022) 1216. https://doi.org/10.3390/pharmaceutics14061216 DOI: https://doi.org/10.3390/pharmaceutics14061216
[13] A. Paci, G. Veal, C. Bardin, D. Levêque, N. Widmer, J. Beijnen. Review of therapeutic drug monitoring of anticancer drugs part 1 - cytotoxics. European Journal of Cancer 50 (2014) 2010-2019. https://doi.org/10.1016/j.ejca.2014.04.014 DOI: https://doi.org/10.1016/j.ejca.2014.04.014
[14] Y. Zhen, A. Thomas-Schoemann, L. Sakji, P. Boudou-Rouquette, N. Dupin, L. Mortier. An HPLC-UV method for the simultaneous quantification of vemurafenib and erlotinib in plasma from cancer patients. Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences 928 (2013) 93-97. https://doi.org/10.1016/j.jchromb.2013.03.017 DOI: https://doi.org/10.1016/j.jchromb.2013.03.017
[15] N.A.G. Lankheet, M.J.X. Hillebrand, H. Rosing, J.H.M. Schellens, J.H. Beijnen, A.D.R. Huitema. Method development and validation for the quantification of dasatinib, erlotinib, gefitinib, imatinib, lapatinib, nilotinib, sorafenib and sunitinib in human plasma by liquid chromatography coupled with tandem mass spectrometry. Biomedical Chromatography 27 (2013) 466-476. https://doi.org/10.1002/bmc.2814 DOI: https://doi.org/10.1002/bmc.2814
[16] H.H. Huynh, C. Pressiat, H. Sauvageon, I. Madelaine, P. Maslanka, C. Lebbé. Development and validation of a simultaneous quantification method of 14 tyrosine kinase inhibitors in human plasma using LC-MS/MS. Therapeutic Drug Monitoring 39 (2017) 43-54. https://doi.org/10.1097/FTD.0000000000000357 DOI: https://doi.org/10.1097/FTD.0000000000000357
[17] L. Gotze, A. Hegele, S.K. Metzelder, H. Renz, W.A. Nockher. Development and clinical application of a LC-MS/MS method for simultaneous determination of various tyrosine kinase inhibitors in human plasma. Clinica Chimica Acta 413 (2012) 143-149. https://doi.org/10.1016/j.cca.2011.09.012 DOI: https://doi.org/10.1016/j.cca.2011.09.012
[18] J. Rodríguez, G. Castañeda, M.C. Delgado, L. Muñoz, I. Lizcano, J.C. Villa. Simultaneous determination of erlotinib and its metabolites in human urine and serum samples by high-performance liquid chromatography. Chromatographia 80 (2017) 793-801. https://doi.org/10.1007/s10337-017-3258-6 DOI: https://doi.org/10.1007/s10337-017-3258-6
[19] C.M. Sturgeon, A. Viljoen. Analytical error and interference in immunoassay: minimizing risk. Annals of Clinical Biochemistry 48 (2011) 418-432. https://doi.org/10.1258/acb.2011.011073 DOI: https://doi.org/10.1258/acb.2011.011073
[20] L.J. Kricka. Interferences in immunoassay — still a threat. Clinical Chemistry 46 (2000) 1037-1038. https://doi.org/10.1093/clinchem/46.8.1037 DOI: https://doi.org/10.1093/clinchem/46.8.1037
[21] J. Tate, G. Ward. Interferences in immunoassay. Clinical Biochemist Reviews 25 (2004) 105-120. PMCID: PMC1904417
[22] D.R. Thévenot, K. Toth, R.A. Durst, G.S. Wilson. Electrochemical biosensors: recommended definitions and classification. Biosensors and Bioelectronics 16 (2001) 121-131. https://doi.org/10.1016/S0956-5663(01)00115-4 DOI: https://doi.org/10.1016/S0956-5663(01)00115-4
[23] N.J. Ronkainen, H.B. Halsall, W.R. Heineman. Electrochemical biosensors. Chemical Society Reviews 39 (2010) 1747-1763. https://doi.org/10.1039/b714449k DOI: https://doi.org/10.1039/b714449k
[24] M. Li, Y.T. Li, D.W. Li, Y.T. Long. Recent developments and applications of screen-printed electrodes in environmental assays — a review. Analytica Chimica Acta 734 (2012) 31-44. https://doi.org/10.1016/j.aca.2012.05.018 DOI: https://doi.org/10.1016/j.aca.2012.05.018
[25] R.A. Couto, J.L. Lima, M.B. Quinaz. Recent developments, characteristics and potential applications of screen-printed electrodes in pharmaceutical and biological analysis. Talanta 146 (2016) 801-814. https://doi.org/10.1016/j.talanta.2015.06.011 DOI: https://doi.org/10.1016/j.talanta.2015.06.011
[26] A. Cetinkaya, S.I. Kaya, G. Ozcelikay, E.B. Atici, S.A. Ozkan. A molecularly imprinted electrochemical sensor based on highly selective and an ultra-trace assay of anti-cancer drug axitinib in its dosage form and biological samples. Talanta 233 (2021) 122569. https://doi.org/10.1016/j.talanta.2021.122569 DOI: https://doi.org/10.1016/j.talanta.2021.122569
[27] Ç.A. Özata, N. Erk, W. Bouali, A.A. Genc, H.E.H. Ahmed, M. Soylak. A novel electrochemical sensor based on NiCaCr-LTH@Nb₂C MXene-modified GCE for the sensitive determination of the anticancer drug gilteritinib. Electrochimica Acta 539 (2025) 147089. https://doi.org/10.1016/j.electacta.2025.147089 DOI: https://doi.org/10.1016/j.electacta.2025.147089
[28] J.P. Metters, R.O. Kadara, C.E. Banks. New directions in screen printed electroanalytical sensors: an overview of recent developments. Analyst 136 (2011) 1067-1076. https://doi.org/10.1039/c0an00894j DOI: https://doi.org/10.1039/c0an00894j
[29] K. Yamanaka, M.C. Vestergaard, E. Tamiya. Printable electrochemical biosensors: a focus on screen-printed electrodes and their application. Sensors 16 (2016) 1761. https://doi.org/10.3390/s16101761 DOI: https://doi.org/10.3390/s16101761
[30] E. Costa-Rama, M.T. Fernández-Abedul. Paper-based screen-printed electrodes: a new generation of low-cost electroanalytical platforms. Biosensors 11 (2021) 51. https://doi.org/10.3390/bios11020051 DOI: https://doi.org/10.3390/bios11020051
[31] F. Arduini, S. Cinti, V. Mazzaracchio, V. Scognamiglio, A. Amine, D. Moscone. Carbon black as an outstanding and multifaceted material for electrochemical biosensor design. Biosensors and Bioelectronics 156 (2020) 112033. https://doi.org/10.1016/j.bios.2020.112033 DOI: https://doi.org/10.1016/j.bios.2020.112033
[32] A. Umar, M. S. Akhtar, M. S. Al-Assiri, A. Al-Hajry, H. Algarni, V. R. de Mendonça, Y. Masuda, S. H. Kim, Q. I. Rahman. Highly porous ZnO nanosheets self-assembled in rosette-like morphologies for dye-sensitized solar cell application. New Journal of Chemistry 39 (2015) 7961-7970. https://doi.org/10.1039/C5NJ00551E DOI: https://doi.org/10.1039/C5NJ00551E
[33] E. Sanattalab, D. Kanarya, A. Ebrahimi, R. Didarian, F. Doğan Güzel, N. Yıldırım Tirgil. Cutting-edge applications of titanium dioxide in biosensors. Electroanalysis 37 (2025) e70049. https://doi.org/10.1002/elan.70049 DOI: https://doi.org/10.1002/elan.70049
[34] X. Luo, A. Morrin, A.J. Killard, M.R. Smyth. Application of nanoparticles in electrochemical sensors and biosensors. Electroanalysis 18 (2006) 319-326. https://doi.org/10.1002/elan.200503415 DOI: https://doi.org/10.1002/elan.200503415
[35] J. Sengupta, C.M. Hussain. Advancements in titanium dioxide nanotube-based sensors for medical diagnostics: a two-decade review. Nanomaterials 15 (2025) 1044. https://doi.org/10.3390/nano15131044 DOI: https://doi.org/10.3390/nano15131044
[36] T. Berger, D. Monllor-Satoca, M. Jankulovska, T. Lana-Villarreal, R. Gómez. The Electrochemistry of Nanostructured Titanium Dioxide Electrodes. ChemPhysChem 13 (2012) 2824-2875 https://doi.org/10.1002/cphc.201200073 DOI: https://doi.org/10.1002/cphc.201200073
[37] E. Pacheco da Silva, M. da Silva Araujo, M.H. Kunita, R. Matos, R.A. Medeiros. Electrochemical sensor based on multi-walled carbon nanotubes and N-doped TiO₂ nanoparticles for voltammetric simultaneous determination of benserazide and levodopa. Molecules 27 (2022) 8614. https://doi.org/10.3390/molecules27238614 DOI: https://doi.org/10.3390/molecules27238614
[38] Y. Guo, D. He, A. Xie, W. Qu, Y. Tang, L. Zhou, R. Zhu. The electrochemical oxidation of hydroquinone and catechol through a novel poly-geminal dicationic ionic liquid (PGDIL)-TiO₂ composite film electrode. Polymers 11 (2019) 1907. https://doi.org/10.3390/polym11111907 DOI: https://doi.org/10.3390/polym11111907
[39] P. Das Manjulabhai, A. Warrier, J. Raveendran, D. Gangadharan. Electrochemical behavior of an anti-cancer drug erlotinib at screen-printed electrode and its analytical application. Current Analytical Chemistry 22 (2026) 417-430. https://doi.org/10.2174/0115734110318492240824112721 DOI: https://doi.org/10.2174/0115734110318492240824112721
[40] OriginLab Corporation, Origin 2026b, https://www.originlab.com/index.aspx?go=Products/ OriginStudentVersion (accessed January 15th, 2026)
[41] T. Joseph, N. Thomas. A facile electrochemical sensor based on titanium oxide (TiO2)/reduced graphene oxide (RGO) nano composite modified carbon paste electrode for sensitive detection of epinephrine (EP) from ternary mixture. Materials Today: Proceedings 41 (2021) 606. https://doi.org/10.1016/j.matpr.2020.05.257 DOI: https://doi.org/10.1016/j.matpr.2020.05.257
[42] Z. He, Y. Zhou, Y. Wang, P. Guo, W. Jiang, C. Yao, X. Shu. Preparation and properties of Ni-WP-TiO2 nanocomposite coatings developed by a sol-enhanced electroplating method. Chinese Journal of Chemical Engineering 44 (2022) 369-376. https://doi.org/10.1016/j.cjche.2021.03.046 DOI: https://doi.org/10.1016/j.cjche.2021.03.046
[43] J. Qiu, S. Zhang, H. Zhao. Recent applications of TiO₂ nanomaterials in chemical sensing in aqueous media. Sensors and Actuators B 156 (2011) 875-890. https://doi.org/10.1016/j.snb.2011.08.077 DOI: https://doi.org/10.1016/j.snb.2011.08.077
[44] P. Sahare, P. G. Alvarez, J. M. S. Yanez, J. G. L. Bárcenas, S. Chakraborty, S. Paul, M. Estevez. Engineered titania nanomaterials in advanced clinical applications. Beilstein Journal of Nanotechnology 13 (2022) 201-218. https://doi.org/10.3762/bjnano.13.15 DOI: https://doi.org/10.3762/bjnano.13.15
[45] A.B. Younis, V. Milosavljevic, T. Fialova, K. Smerkova, H. Michalkova, P. Svec. Synthesis and characterization of TiO₂ nanoparticles combined with geraniol and their synergistic antibacterial activity. BMC Microbiology 23 (2023) 207. https://doi.org/10.1186/s12866-023-02955-1 DOI: https://doi.org/10.1186/s12866-023-02955-1
[46] G. Nabi, N.R. Khalid, M.B. Tahir, M. Rafique, M. Rizwan, S. Hussain. A review on novel eco-friendly green approach to synthesis TiO₂ nanoparticles using different extracts. Journal of Inorganic and Organometallic Polymers and Materials 31 (2021) 835-848. https://doi.org/10.1007/s10904-018-0812-0 DOI: https://doi.org/10.1007/s10904-018-0812-0
[47] M. A. Vasanth, V. Vishnu, J. Ks, G. Kurian. Physiochemical investigation and biovaluation of TiO2 nanocrystals synthesized by chemical and green route. International Journal of Pharmacy and Pharmaceutical Sciences 6 (2014) 60-64. https://journals.innovareacademics.in/index.php/ijpps/article/view/2829
[48] H. Barich, O. Voet, N. Sleegers, K. De Wael. Selecting optimal carbon inks for fabricating high-performance screen-printed electrodes for diverse electroanalytical applications. Journal of Electroanalytical Chemistry 969 (2024) 118585. https://doi.org/10.1016/j.jelechem.2024.118585 DOI: https://doi.org/10.1016/j.jelechem.2024.118585
[49] T.C. de Oliveira Cândido, A.C. Pereira, D.N. da Silva. Development and characterization of conductive ink composed of graphite and carbon black for application in printed electrodes. Analytica 4 (2023) 513-526. https://doi.org/10.3390/analytica4040035 DOI: https://doi.org/10.3390/analytica4040035
[50] A.G.-M. Ferrari, S.J. Rowley-Neale, C.E. Banks. Screen-printed electrodes: transitioning the laboratory in-to-the field. Talanta Open 3 (2021) 100032. https://doi.org/10.1016/j.talo.2021.100032 DOI: https://doi.org/10.1016/j.talo.2021.100032
[51] F. Riesco, G. A. Cosco-Salguero, E. Nagles, J. Penagos-Llanos, R. Segura, J. Hurtado. New Screen-Printed Carbon Electrodes Molecularly Modified with Methylphenidate Film for Electrochemical Determination of Dopamine by Linear Scan Voltammetry. Electroanalysis 37 (2025) e12028. https://doi.org/10.1002/elan.12028 DOI: https://doi.org/10.1002/elan.12028
[52] S. Trasatti, O.A. Petrii. Real surface area measurements in electrochemistry. Journal of Electroanalytical Chemistry 327 (1992) 353-376. https://doi.org/10.1016/0022-0728(92)80162-W DOI: https://doi.org/10.1016/0022-0728(92)80162-W
[53] A. García-Miranda Ferrari, C.W. Foster, P.J. Kelly, D.A.C. Brownson, C.E. Banks. Determination of the electrochemical area of screen-printed electrochemical sensing platforms. Biosensors 8 (2018) 53. https://doi.org/10.3390/bios8020053 DOI: https://doi.org/10.3390/bios8020053
[54] E. Laviron. General expression of the linear potential sweep voltammogram in the case of diffusionless electrochemical systems. Journal of Electroanalytical Chemistry and Interfacial Electrochemistry 101 (1979) 19-28. https://doi.org/10.1016/S0022-0728(79)80075-3 DOI: https://doi.org/10.1016/S0022-0728(79)80075-3
[55] N. Elgrishi, K.J. Rountree, B.D. McCarthy, E.S. Rountree, T.T. Eisenhart, J.L. Dempsey. A practical beginner's guide to cyclic voltammetry. Journal of Chemical Education 95 (2018) 197-206. https://doi.org/10.1021/acs.jchemed.7b00361 DOI: https://doi.org/10.1021/acs.jchemed.7b00361
[56] A.J. Bard, L.R. Faulkner. Electrochemical Methods: Fundamentals and Applications, 2nd ed., John Wiley & Sons, New York, USA, 2011, p. 231-234. ISBN: 978-1-118-31280-3. https://www.wiley.com/en-be/shop/general-chemistry/electrochemical-methods-fundamentals-and-applications-2nd-edition-p-9781118312803
[57] E.P. Randviir. A cross examination of electron transfer rate constants for carbon screen-printed electrodes using electrochemical impedance spectroscopy and cyclic voltammetry. Electrochimica Acta 286 (2018) 179-186. https://doi.org/10.1016/j.electacta.2018.08.021 DOI: https://doi.org/10.1016/j.electacta.2018.08.021
[58] R. Gusmão, V. López-Puente, L. Yate, I. Pastoriza-Santos, J. Perez-Juste, E. Gonzalez-Romero. Screen-printed carbon electrodes doped with TiO2-Au nanocomposites with improved electrocatalytic performance. Materials Today Communications 11 (2017) 11-17. https://doi.org/10.1016/j.mtcomm.2017.02.003 DOI: https://doi.org/10.1016/j.mtcomm.2017.02.003
[59] H.O. Finklea. Theory of coupled electron-proton transfer with potential-dependent transfer coefficients for redox couples attached to electrodes. The Journal of Physical Chemistry B 105 (2001) 8685-8693. https://doi.org/10.1021/jp010768l DOI: https://doi.org/10.1021/jp010768l
[60] N.K. Bakirhan, T. Taskin Tok, S.A. Ozkan. The redox mechanism investigation of non-small cell lung cancer drug: erlotinib via theoretical and experimental techniques and its host-guest detection by β-cyclodextrin nanoparticles modified glassy carbon electrode. Sensors and Actuators B 278 (2019) 172-180. https://doi.org/10.1016/j.snb.2018.09.090 DOI: https://doi.org/10.1016/j.snb.2018.09.090
[61] L. Bertel, D.A. Miranda, J.M. García-Martín. Nanostructured titanium dioxide surfaces for electrochemical biosensing. Sensors 21 (2021) 6167. https://doi.org/10.3390/s21186167 DOI: https://doi.org/10.3390/s21186167
[62] J. Fujisawa, S. Kato, M. Hanaya. Aromatic-ring dependence of interfacial charge-transfer transitions between TiO2 nanoparticles and aromatic carboxylic acids. Chemical Physics Letters 788 (2022) 139274. https://doi.org/10.1016/j.cplett.2021.139274 DOI: https://doi.org/10.1016/j.cplett.2021.139274
[63] R.D. Crapnell, A. Garcia-Miranda Ferrari, N.C. Dempsey, C.E. Banks. Electroanalytical overview: screen-printed electrochemical sensing platforms for the detection of vital cardiac, cancer and inflammatory biomarkers. Sensors and Diagnostics 1 (2022) 405-428. https://doi.org/10.1039/D1SD00041A DOI: https://doi.org/10.1039/D1SD00041A
[64] J.F. Pereira, M. Bertotti, E.V. Dos Santos, C.A. Martínez-Huitle. Beyond equations: experimental insights into detection limits in electroanalysis. Talanta 310 (2026) 130077. https://doi.org/10.1016/j.talanta.2026.130077 DOI: https://doi.org/10.1016/j.talanta.2026.130077
[65] C.E. Ott. Strategies for assessing the limit of detection in voltammetric methods: comparison and evaluation of approaches. Analyst 149 (2024) 4295-4309. https://doi.org/10.1039/d4an00636d DOI: https://doi.org/10.1039/D4AN00636D
[66] A.R. Masters, C.J. Sweeney, D.R. Jones. The quantification of erlotinib (OSI-774) and OSI-420 in human plasma by liquid chromatography-tandem mass spectrometry. Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences 848 (2007) 379-383. https://doi.org/10.1016/j.jchromb.2006.10.046 DOI: https://doi.org/10.1016/j.jchromb.2006.10.046
[67] S. Bouchet, E. Chauzit, D. Ducint, N. Castaing, M. Canal-Raffin, N. Moore. Simultaneous determination of nine tyrosine kinase inhibitors by 96-well solid-phase extraction and ultra performance LC/MS-MS. Clinica Chimica Acta 412 (2011) 1060-1067. https://doi.org/10.1016/j.cca.2011.02.023 DOI: https://doi.org/10.1016/j.cca.2011.02.023
[68] N.T. Ramarao, S. Vidyadhara, M.V. Basaveswara Rao, R.L.C. Sasidhar, R. Surendra Yadav. Liquid chromatography-tandem mass spectrometry method development and validation for the determination of erlotinib in human plasma and its application in pharmacokinetic study. Journal of Analytical Chemistry 70 (2015) 1488-1494. https://doi.org/10.1134/S1061934815120151 DOI: https://doi.org/10.1134/S1061934815120151
[69] A. van Veelen, R. van Geel, R. Schoufs, Y. de Beer, L.M. Stolk, L.E. Hendriks. Development and validation of an HPLC-MS/MS method to simultaneously quantify alectinib, crizotinib, erlotinib, gefitinib and osimertinib in human plasma samples, using one assay run. Biomedical Chromatography 35 (2021) e5224. https://doi.org/10.1002/bmc.5224 DOI: https://doi.org/10.1002/bmc.5224
[70] J. Rodríguez, G. Castañeda, L. Muñoz, D. Navarro, J.C. Villa. Simultaneous determination of erlotinib and metabolites in human urine using capillary electrophoresis. Electrophoresis 35 (2014) 1489-1495. https://doi.org/10.1002/elps.201300573 DOI: https://doi.org/10.1002/elps.201300573
[71] Z. Es'haghi, F. Moeinpour. Carbon nanotube/polyurethane modified hollow fiber-pencil graphite electrode for in situ concentration and electrochemical quantification of anticancer drugs capecitabine and erlotinib. Engineering in Life Sciences 19 (2019) 302-314. https://doi.org/10.1002/elsc.201800167 DOI: https://doi.org/10.1002/elsc.201800167
[72] H. Rahmanian, Z. Es'haghi, M. Dadmehr. A robust electrochemical sensing platform for the detection of erlotinib based on nitrogen-doped graphene quantum dots/copper nanoparticles-polyaniline-graphene oxide nanohybrid. Nanotechnology 34 (2023) 015502. https://doi.org/10.1088/1361-6528/ac8996 DOI: https://doi.org/10.1088/1361-6528/ac8996
[73] D.E. Bayraktepe, C. Yıldız, Z. Yazan. The development of electrochemical DNA biosensor based on poly-l-methionine and bimetallic AuPt nanoparticles coating: picomolar detection of imatinib and erlotinib. Talanta 257 (2023) 124361. https://doi.org/10.1016/j.talanta.2023.124361 DOI: https://doi.org/10.1016/j.talanta.2023.124361
[74] S.A. Ahmed, M. Roushani, Z. Mirzaei Karazan. Development of a molecularly imprinted electrochemical sensor for erlotinib detection using a modified screen-printed carbon electrode. Microchimica Acta 192 (2025) 138. https://doi.org/10.1007/s00604-025-07012-4 DOI: https://doi.org/10.1007/s00604-025-07012-4
[75] F. Hasanpour, M. Fouladgar. A novel electrochemical sensor for the determination of the non-small cell lung cancer drug erlotinib using p-type cuprous delafossite CuBO₂ nanosheets and graphene quantum dots. Journal of Analytical Chemistry 80 (2025) 1810-1818. https://doi.org/10.1134/S1061934825601306 DOI: https://doi.org/10.1134/S1061934825601306
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Pooja Das Manjulabhai, Sruthi Mundangadan , Maria Paul, Srinivedha Lal, Namitha Ramalal, Mariya Anto, Dhanya Gangadharan
This work is licensed under a Creative Commons Attribution 4.0 International License.
How to Cite
Funding data
-
APJ Abdul Kalam Technological University
Grant numbers U.O.No. 539/2021/KTU
